200 related articles for article (PubMed ID: 30005210)
1. Characterization of long non-coding RNAs and MEF2C-AS1 identified as a novel biomarker in diffuse gastric cancer.
Luo T; Zhao J; Lu Z; Bi J; Pang T; Cui H; Yang B; Li W; Wang Y; Wu S; Xue X
Transl Oncol; 2018 Oct; 11(5):1080-1089. PubMed ID: 30005210
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
[TBL] [Abstract][Full Text] [Related]
3. The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer.
Ke D; Li H; Zhang Y; An Y; Fu H; Fang X; Zheng X
Oncotarget; 2017 Mar; 8(13):21516-21525. PubMed ID: 28423525
[TBL] [Abstract][Full Text] [Related]
4. The novel long noncoding RNA RP11-357H14.17 acts as an oncogene by promoting cell proliferation and invasion in diffuse-type gastric cancer.
Yang B; Luo T; Zhang M; Lu Z; Xue X; Fang G
Onco Targets Ther; 2017; 10():2635-2643. PubMed ID: 28572735
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of lncRNAs in circulation of patients with periodontitis: results of a pilot study.
Ghafouri-Fard S; Gholami L; Badrlou E; Sadeghpour S; Nazer N; Shadnoush M; Sayad A; Taheri M
BMC Oral Health; 2021 Sep; 21(1):471. PubMed ID: 34563175
[TBL] [Abstract][Full Text] [Related]
6. Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer.
Dang Y; Lan F; Ouyang X; Wang K; Lin Y; Yu Y; Wang L; Wang Y; Huang Q
World J Surg Oncol; 2015 Oct; 13():302. PubMed ID: 26472090
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of long non-coding RNAs in human gastric cancer: An in silico study.
Han W; Zhang Z; He B; Xu Y; Zhang J; Cao W
PLoS One; 2017; 12(8):e0183517. PubMed ID: 28841672
[TBL] [Abstract][Full Text] [Related]
8. Expression levels and associations of five long non-coding RNAs in gastric cancer and their clinical significance.
Binang HB; Wang YS; Tewara MA; Du L; Shi S; Li N; Nsenga AGA; Wang C
Oncol Lett; 2020 Mar; 19(3):2431-2445. PubMed ID: 32194743
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
[TBL] [Abstract][Full Text] [Related]
10. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of lncRNA TP73-AS1 inhibits gastric cancer cell proliferation and invasion via the WNT/β-catenin signaling pathway.
Wang Y; Xiao S; Wang B; Li Y; Chen Q
Oncol Lett; 2018 Sep; 16(3):3248-3254. PubMed ID: 30127921
[TBL] [Abstract][Full Text] [Related]
12. Genome-Wide Analysis of Long Noncoding RNA Expression Profiles in Human Xuanwei Lung Cancer.
Li Q; Wu C; Song G; Zhang H; Shan B; Duan Y; Wang Y
Clin Lab; 2015; 61(10):1515-23. PubMed ID: 26642714
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of LncRNA SLC25A25-AS1 promotes proliferation, chemoresistance, and EMT in colorectal cancer cells.
Li Y; Huang S; Li Y; Zhang W; He K; Zhao M; Lin H; Li D; Zhang H; Zheng Z; Huang C
Tumour Biol; 2016 Oct; 37(10):14205-14215. PubMed ID: 27553025
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway.
Wu X; Zhang P; Zhu H; Li S; Chen X; Shi L
Biomed Pharmacother; 2017 Dec; 96():1103-1108. PubMed ID: 29239821
[TBL] [Abstract][Full Text] [Related]
15. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of the long non-coding RNA MLLT4 antisense RNA 1 is a potential biomarker and an indicator of a poor prognosis for gastric cancer.
Lai Y; Xu P; Liu J; Li Q; Ren D; Zhang J; Wang J
Oncol Lett; 2017 Sep; 14(3):2629-2634. PubMed ID: 28927028
[TBL] [Abstract][Full Text] [Related]
17. The value of lncRNA
Herrera-Merchan A; Cuadros M; Rodriguez MI; Rodriguez S; Torres R; Estecio M; Coira IF; Loidi C; Saiz M; Carmona-Saez P; Medina PP
Oncotarget; 2020 Mar; 11(13):1172-1185. PubMed ID: 32284793
[TBL] [Abstract][Full Text] [Related]
18. High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer.
Lv J; Qiu M; Xia W; Liu C; Xu Y; Wang J; Leng X; Huang S; Zhu R; Zhao M; Ji F; Xu L; Xu K; Yin R
J Exp Clin Cancer Res; 2016 May; 35():75. PubMed ID: 27154193
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis of the gastric cancer long non-coding RNA-associated competing endogenous RNA network.
Jiang Y; Zhang X; Rong L; Hou Y; Song J; Zhang W; He M; Xie Y; Li Y; Song F
Oncol Lett; 2021 Jun; 21(6):456. PubMed ID: 33907566
[TBL] [Abstract][Full Text] [Related]
20. LncRNA FENDRR-mediated tumor suppression and tumor-immune microenvironment changes in non-small cell lung cancer.
Pan H; Yu T; Sun L; Chai W; Liu X; Yan M
Transl Cancer Res; 2020 Jun; 9(6):3946-3959. PubMed ID: 35117761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
